drugset
drugset / Trial / NCT02504463

A Study of [14c]-Samidorphan (Also Known as ALKS 33) in Healthy, Male Volunteers

NCT02504463 ↗

Phase 1 Completed 10 enrolled Alkermes, Inc.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study will determine the pharmacokinetics (PK) of \[14c\]-samidorphan in healthy male volunteers.

Timeline

Start
2015-06
Primary completion
2015-09
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Samidorphan Small molecule — Intravenous

Indications

No indication recorded.